Skip Navigation


Rheumatology Advance Access originally published online on August 1, 2007
Rheumatology 2007 46(9):1492-1494; doi:10.1093/rheumatology/kem182
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
46/9/1492    most recent
kem182v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Yu, H.-H.
Right arrow Articles by Chiang, B.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, H.-H.
Right arrow Articles by Chiang, B.-L.
Related Collections
Right arrow Systemic Lupus Erythematosus and Autoimmunity
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients

H.-H. Yu, L.-C. Wang, J.-H. Lee, C.-C. Lee1, Y.-H. Yang and B.-L. Chiang

Department of Pediatrics and 1Department of Emergency Medicine, National Taiwan University Hospital, Taipei, Taiwan, Republic of China.

Correspondence to: Dr Bor-Luen Chiang, Department of Pediatrics, National Taiwan University Hospital, # 7 Chung-Shan South Road, Taipei, Taiwan, Republic of China. E-mail: gicmbor{at}ntu.edu.tw


   Abstract

Objectives. To investigate if lymphopenia is associated with clinical manifestations, disease activity and prognosis in systemic lupus erythematosus (SLE).

Methods. The charts of 186 paediatric patients with SLE diagnosed between 1985 and 2006 in a medical centre were retrospectively reviewed. Lymphocyte counts were recorded at the time of SLE diagnosis and SLE flares. Global disease activity was quantified by the SLE Disease Activity Index (SLEDAI). Cumulative organ damage was assessed by the ACR/Systemic Lupus International Collaborating Clinics (SLICC) damage index.

Results. Lymphopenia (<1500/mm3) and marked lymphopenia (<500/mm3) was observed in 62.8 and 12.2% at the time of SLE diagnosis. At the time of SLE diagnosis, lymphopenia was significantly associated with oral ulcers, leucopenia, anti-dsDNA antibodies and C4 decrease. At the time of flares, lymphopenia was significantly associated with anti-dsDNA antibodies, methylprednisolone pulse therapy, disease activity and organ damage. Using multivariate logistic regression, marked lymphopenia was independently associated with neuropsychiatric manifestations [odds ratio (OR) 7.41, 95% confidence interval (CI) 1.99–27.0], and protective from LN (OR 0.13, 95% CI 0.03–0.53).

Conclusions. Lymphopenia at SLE flares is associated with disease activity and organ damage. Marked lymphopenia is independently associated with neuropsychiatric manifestations.

KEY WORDS: Lymphopenia, Systemic lupus erythematosus, SLE, Neuropsychiatric lupus

Submitted 22 March 2007; Accepted 8 June 2007


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
N. Mozaffarian, A. E. Wiedeman, and A. M. Stevens
Active systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1
Rheumatology, September 1, 2008; 47(9): 1335 - 1341.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.